Physician

Albert James Chang, MD PHD

According to 2025 Medicare claims, Albert Chang, MD PHD (NPI: 1104089267) practices radiation oncology in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (NPI: 1730143454; TIN: 954377219) and primary practice location at 90095-8358. Chang is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Chang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 335 traditional Medicare patients, billed 2,556 HCPCS/CPT codes, and received $282,170 in Medicare payments. The top billing code was 77295 (3d radiation therapy planning). Part D data shows 60 prescription claims across 35 beneficiaries totaling $11,351 in drug costs, led by Tamsulosin Hcl (Tamsulosin Hcl). Open Payments data shows 104 records totaling $58,804. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $167,789 to $282,170. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $9,133 and ending at $11,351. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$142K$284K2015 Medicare payment: $167,789 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $170,730 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $156,933 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $284,217 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $241,205 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $265,807 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $282,374 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $269,610 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $274,812 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $282,170 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152931,606$167,789
20163521,655$170,730
20172791,252$156,933
20182422,529$284,217
20192112,174$241,205
20202342,158$265,807
20212482,288$282,374
20222562,331$269,610
20233022,484$274,812
20243352,556$282,170

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$22K$44K2015 Drug cost: $9,133 (USD; Tot_Drug_Cst)2016 Drug cost: $6,229 (USD; Tot_Drug_Cst)2017 Drug cost: $10,912 (USD; Tot_Drug_Cst)2018 Drug cost: $5,059 (USD; Tot_Drug_Cst)2019 Drug cost: $1,502 (USD; Tot_Drug_Cst)2020 Drug cost: $6,666 (USD; Tot_Drug_Cst)2021 Drug cost: $31,744 (USD; Tot_Drug_Cst)2022 Drug cost: $44,041 (USD; Tot_Drug_Cst)2023 Drug cost: $42,859 (USD; Tot_Drug_Cst)2024 Drug cost: $11,351 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201571269$9,133
201692290$6,229
2017111437$10,912
201851122$5,059
20193356$1,502
20203773$6,666
20212660$31,744
20222353$44,041
20233366$42,859
20243560$11,351

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
772953d radiation therapy planning118155$187
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more154154$145
77263Complex radiation therapy planning136139$138
77470Special radiation treatment134137$89
77334Design and construction of complex radiation treatment device123301$51

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Tamsulosin HclTamsulosin Hcl281,867$595

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.104$58,804Boston Scientific Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Albert James Chang, MD PHD?

Tedicare shows public-source Medicare data for Albert James Chang, MD PHD (NPI 1104089267), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Albert James Chang, MD PHD have ACO affiliation data?

Albert James Chang, MD PHD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Albert James Chang, MD PHD?

Albert James Chang, MD PHD is linked to THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (billing NPI 1730143454) in the available physician profile data.

Does Albert James Chang, MD PHD have Open Payments data?

Albert James Chang, MD PHD has 104 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.